These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19902860

  • 1. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
    Bhattacharya S, Vijayasekar C, Worlding J, Mathew G.
    Acta Gastroenterol Belg; 2009; 72(3):289-95. PubMed ID: 19902860
    [Abstract] [Full Text] [Related]

  • 2. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 3. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review.
    Deng C, Deng B, Jia L, Tan H.
    BMJ Open; 2017 Jun 21; 7(6):e014916. PubMed ID: 28637728
    [Abstract] [Full Text] [Related]

  • 5. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
    Pai V, Porter K, Ranalli M.
    Pediatr Blood Cancer; 2011 Jan 21; 56(1):45-9. PubMed ID: 21108438
    [Abstract] [Full Text] [Related]

  • 6. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J, Haim N, Beny A, Stein M, Gez E, Kuten A.
    Ann Oncol; 2001 Feb 21; 12(2):227-9. PubMed ID: 11300329
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun 21; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 8. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S, Benson AB, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E.
    J Clin Oncol; 1998 Sep 21; 16(9):3169-78. PubMed ID: 9738589
    [Abstract] [Full Text] [Related]

  • 9. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun 21; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

  • 10. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
    Sun JX, Yang N.
    Asia Pac J Clin Oncol; 2014 Jun 21; 10(2):e108-13. PubMed ID: 23297685
    [Abstract] [Full Text] [Related]

  • 11. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
    Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H.
    Bone Marrow Transplant; 1997 Nov 21; 20(9):711-4. PubMed ID: 9384471
    [Abstract] [Full Text] [Related]

  • 12. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
    Cascinu S, Fedeli A, Fedeli SL, Catalano G.
    J Clin Oncol; 1993 Jan 21; 11(1):148-51. PubMed ID: 8418225
    [Abstract] [Full Text] [Related]

  • 13. Systematic review: the use of somatostatin or octreotide in refractory diarrhoea.
    Szilagyi A, Shrier I.
    Aliment Pharmacol Ther; 2001 Dec 21; 15(12):1889-97. PubMed ID: 11736719
    [Abstract] [Full Text] [Related]

  • 14. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Dec 21; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 15. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
    Gebbia V, Carreca I, Testa A, Valenza R, Curto G, Cannata G, Borsellino N, Latteri MA, Cipolla C, Florena M.
    Anticancer Drugs; 1993 Aug 21; 4(4):443-5. PubMed ID: 8400346
    [Abstract] [Full Text] [Related]

  • 16. Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil.
    Cascinu S, Fedeli A, Fedeli SL, Catalano G.
    Eur J Cancer; 1992 Aug 21; 28(2-3):482-3. PubMed ID: 1591068
    [Abstract] [Full Text] [Related]

  • 17. Octreotide in the management of treatment-related diarrhoea.
    Baillie-Johnson HR.
    Anticancer Drugs; 1996 Jan 21; 7 Suppl 1():11-5. PubMed ID: 8822080
    [Abstract] [Full Text] [Related]

  • 18. Octreotide treatment of chemotherapy-induced diarrhoea.
    Ginopoulos P, Papagiannis T, Safridi C, Karvelas F, Spyropoulos K, Papadas T, Gogos C.
    Eur J Cancer; 1996 Jan 21; 32A(1):182-3. PubMed ID: 8695236
    [No Abstract] [Full Text] [Related]

  • 19. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST.
    Cancer Chemother Pharmacol; 2014 Oct 21; 74(4):675-80. PubMed ID: 25055935
    [Abstract] [Full Text] [Related]

  • 20. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
    Crouch MA, Restino MS, Cruz JM, Perry JJ, Hurd DD.
    Ann Pharmacother; 1996 Apr 21; 30(4):331-6. PubMed ID: 8729883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.